Different adipose depots: Their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents

Journal of Obesity

Volumn 2011, Issue , 2011, Pages

  Bjørndal, Bodil ^a   Burri, Lena ^a   Staalesen, Vidar ^a   Skorve, Jon ^a   Berge, Rolf K ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860252542     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2011/490650     Document Type: Review

References (148)

1. Muoio D. M. Newgard C. B. Obesity-related derangements in metabolic regulation. Annual Review of Biochemistry 2006 75 367 401 2-s2.0-33746377553 10.1146/annurev.biochem.75.103004.142512 (Pubitemid 44118037)
2. Sethi J. K. Vidal-Puig A. J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. Journal of Lipid Research 2007 48 6 1253 1262 2-s2.0-34250710450 10.1194/jlr.R700005-JLR200 (Pubitemid 47312027)
3. Frühbeck G. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods in Molecular Biology 2008 456 1 22 2-s2.0-48049094196 10.1007/978-1-59745-245-8-1
4. Adams L. A. Lymp J. F. St Sauver J. Sanderson S. O. Lindor K. D. Feldstein A. Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005 129 1 113 121 2-s2.0-22344452893 10.1053/j.gastro.2005.04.014 (Pubitemid 41002048)
5. Puddu P. Puddu G. M. Cravero E. de Pascalis S. Muscari A. The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis. Journal of Biomedical Science 2009 16 112 120 2-s2.0-76249124669 10.1186/1423-0127-16-112
6. Gutierrez D. A. Puglisi M. J. Hasty A. H. Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Current Diabetes Reports 2009 9 1 26 32 2-s2.0-59749094309 10.1007/s11892-009-0006-9
7. Engfeldt P. Arner P. Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Hormone and Metabolic Research. Supplement 1988 19 26 29 2-s2.0-0024253488 (Pubitemid 19005617)
8. McQuaid S. E. Hodson L. Neville M. J. Down-regulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 2011 60 1 47 55
9. Lenzen S. Drinkgern J. Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology and Medicine 1996 20 3 463 466 2-s2.0-0029984682 10.1016/0891-5849(96) 02051-5 (Pubitemid 26077870)
10. Lowell B. B. Shulman G. I. Mitochondrial dysfunction and type 2 diabetes. Science 2005 307 5708 384 387 2-s2.0-12344305124 10.1126/science.1104343 (Pubitemid 40139974)
11. Maassen J. A. Mitochondria, body fat and type 2 diabetes: what is the connection? Minerva Medica 2008 99 3 241 251 2-s2.0-46449123752 (Pubitemid 351929717)
12. Talior I. Yarkoni M. Bashan N. Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC- δ activation in adipocytes of obese, insulin-resistant mice. American Journal of Physiology 2003 285 2 E295 E302 2-s2.0-0042804808 (Pubitemid 36899702)
13. Furukawa S. Fujita T. Shimabukuro M. Iwaki M. Yamada Y. Nakajima Y. Nakayama O. Makishima M. Matsuda M. Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of Clinical Investigation 2004 114 12 1752 1761 2-s2.0-15244342531 10.1172/JCI200421625 (Pubitemid 40385531)
14. Curtis J. M. Grimsrud P. A. Wright W. S. Xu X. Foncea R. E. Graham D. W. Brestoff J. R. Wiczer B. M. Ilkayeva O. Cianflone K. Muoio D. E. Arriaga E. A. Bernlohr D. A. Downregulation of adipose glutathione S-tansferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 2010 59 5 1132 1142 2-s2.0-77951842594 10.2337/db09-1105
15. St-Pierre J. Buckingham J. A. Roebuck S. J. Brand M. D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. The Journal of Biological Chemistry 2002 277 47 44784 44790 2-s2.0-0037160091 10.1074/jbc.M207217200 (Pubitemid 36159072)
16. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. The Journal of Clinical Investigation 2009 119 3 573 581 2-s2.0-67650815430 10.1172/JCI37048
17. Houstis N. Rosen E. D. Lander E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 7086 944 948 2-s2.0-33645860825 10.1038/nature04634
18. Bedard K. Krause K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005 (Pubitemid 46209993)
19. Guichard C. Moreau R. Pessayre D. Epperson T. K. Krause K. H. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes? Biochemical Society Transactions 2008 36 5 920 929 2-s2.0-53849124696 10.1042/BST0360920
20. Wilson-Fritch L. Burkart A. Bell G. Mendelson K. Leszyk J. Nicoloro S. Czech M. Corvera S. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Molecular and Cellular Biology 2003 23 3 1085 1094 2-s2.0-0037304599 10.1128/MCB.23.3.1085-1094.2003 (Pubitemid 36133524)
21. Goldstein B. J. Kalyankar M. Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 2005 54 2 311 321 2-s2.0-12744279326 10.2337/diabetes.54.2.311
22. Carrière A. Fernandez Y. Rigoulet M. Pénicaud L. Casteilla L. Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Letters 2003 550 1-3 163 167 2-s2.0-0142038998 10.1016/S0014-5793(03)00862-7 (Pubitemid 37281375)
23. Carrière A. Carmona M. C. Fernandez Y. Rigoulet M. Wenger R. H. Pénicaud L. Casteilla L. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. The Journal of Biological Chemistry 2004 279 39 40462 40469 2-s2.0-4644329647 10.1074/jbc.M407258200 (Pubitemid 39287636)
24. Rogge M. M. The role of impaired mitochondrial lipid oxidation in obesity. Biological Research for Nursing 2009 10 4 356 373 2-s2.0-63849315875 10.1177/1099800408329408
25. Højlund K. Mogensen M. Sahlin K. Beck-Nielsen H. Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinology and Metabolism Clinics of North America 2008 37 3 713 731 2-s2.0-50449084335 10.1016/j.ecl.2008.06.006
26. Gaster M. Rustan A. C. Aas V. Beck-Nielsen H. Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes. Diabetes 2004 53 3 542 548 2-s2.0-1442326017 10.2337/diabetes.53.3.542 (Pubitemid 38270621)
27. Blaak E. E. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. Best Practice and Research: Clinical Endocrinology and Metabolism 2005 19 3 391 403 2-s2.0-24644499105 10.1016/j.beem.2005.04.001 (Pubitemid 41263794)
28. Kelley D. E. Skeletal muscle fat oxidation: timing and flexibility are everything. The Journal of Clinical Investigation 2005 115 7 1699 1702 2-s2.0-22144484448 10.1172/JCI25758 (Pubitemid 40979705)
29. Ukropcova B. McNeil M. Sereda O. de Jonge L. Xie H. Bray G. A. Smith S. R. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. The Journal of Clinical Investigation 2005 115 7 1934 1941 2-s2.0-22144472218 10.1172/JCI24332 (Pubitemid 40979733)
30. Patti M. E. Butte A. J. Crunkhorn S. Cusi K. Berria R. Kashyap S. Miyazaki Y. Kohane I. Costello M. Saccone R. Landaker E. J. Goldfine A. B. Mun E. DeFronzo R. Finlayson J. Kahn C. R. Mandarino L. J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8466 8471 2-s2.0-0037477855 10.1073/pnas.1032913100 (Pubitemid 36842568)
31. Petersen K. F. Dufour S. Befroy D. Garcia R. Shulman G. I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. The New England Journal of Medicine 2004 350 7 664 671 2-s2.0-1642377274 10.1056/NEJMoa031314 (Pubitemid 38364625)
32. Franckhauser S. Muñoz S. Pujol A. Casellas A. Riu E. Otaegui P. Su B. Bosch F. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 2002 51 3 624 630 2-s2.0-0036317748 (Pubitemid 34760168)
33. Olswang Y. Cohen H. Papo O. Cassuto H. Croniger C. M. Hakimi P. Tilghman S. M. Hanson R. W. Reshef L. A mutation in the peroxisome proliferator-activated receptor γ -binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proceedings of the National Academy of Sciences of the United States of America 2002 99 2 625 630 2-s2.0-0037154217 10.1073/pnas.022616299 (Pubitemid 34106562)
34. Fassina G. Dorigo P. Gaion R. M. Equilibrium between metabolic pathways producing energy: a key factor in regulating lipolysis. Pharmacological Research Communications 1974 6 1 1 21 2-s2.0-0015987288
35. Daval M. Diot-Dupuy F. Bazin R. Hainault I. Viollet B. Vaulont S. Hajduch E. Ferré P. Foufelle F. Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes. The Journal of Biological Chemistry 2005 280 26 25250 25257 2-s2.0-21644455008 10.1074/jbc.M414222200 (Pubitemid 40934619)
36. Wilson-Fritch L. Nicoloro S. Chouinard M. Lazar M. A. Chui P. C. Leszyk J. Straubhaar J. Czech M. P. Corvera S. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. The Journal of Clinical Investigation 2004 114 9 1281 1289 2-s2.0-13844273390 10.1172/JCI200421752 (Pubitemid 40385299)
37. Deveaud C. Beauvoit B. Salin B. Schaeffer J. Rigoulet M. Regional differences in oxidative capacity of rat white adipose tissue are linked to the mitochondrial content of mature adipocytes. Molecular and Cellular Biochemistry 2004 267 1-2 157 166 2-s2.0-9444220793 10.1023/B:MCBI.0000049374.52989.9b (Pubitemid 39562396)
38. Kraunsoe R. Boushel R. Hansen C. N. Schjerling P. Qvortrup K. St M. Mikines K. J. Dela F. fdela@mfi.ku.dk Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity. Journal of Physiology 2010 588 12 2023 2032 10.1113/jphysiol.2009.184754
39. Bogacka I. Xie H. Bray G. A. Smith S. R. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes 2005 54 5 1392 1399 2-s2.0-17844385363 10.2337/diabetes.54.5.1392 (Pubitemid 40586669)
40. Kaaman M. Sparks L. M. van Harmelen V. Smith S. R. Sjölin E. Dahlman I. Arner P. Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia 2007 50 12 2526 2533 2-s2.0-35848966984 10.1007/s00125-007-0818-6 (Pubitemid 350060639)
41. Petersen K. F. Befroy D. Dufour S. Dziura J. Ariyan C. Rothman D. L. DiPietro L. Cline G. W. Shulman G. I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003 300 5622 1140 1142 2-s2.0-0038025371 10.1126/science.1082889 (Pubitemid 36583097)
42. Pessayre D. Fromenty B. Mansouri A. Mitochondrial injury in steatohepatitis. European Journal of Gastroenterology and Hepatology 2004 16 11 1095 1105 2-s2.0-8444226753 10.1097/00042737-200411000-00003 (Pubitemid 39488778)
43. Rong J. X. Qiu Y. Hansen M. K. Zhu L. Zhang V. Xie MI. Okamoto Y. Mattie M. D. Higashiyama H. Asano S. Strum J. C. Ryan T. E. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 2007 56 7 1751 1760 2-s2.0-34347391646 10.2337/db06-1135 (Pubitemid 47025441)
44. van Marken Lichtenbelt W. D. Vanhommerig J. W. Smulders N. M. Drossaerts J. M. A. F. L. Kemerink G. J. Bouvy N. D. Schrauwen P. Teule G. J. J. Cold-activated brown adipose tissue in healthy men. The New England Journal of Medicine 2009 360 15 1500 1508 2-s2.0-64349095231 10.1056/NEJMoa0808718
45. Virtanen K. A. Lidell M. E. Orava J. Heglind M. Westergren R. Niemi T. Taittonen M. Laine J. Savisto N. J. Enerbäck S. Nuutila P. Functional brown adipose tissue in healthy adults. The New England Journal of Medicine 2009 360 15 1518 1525 2-s2.0-64349123664 10.1056/NEJMoa0808949
46. Seale P. Bjork B. Yang W. Kajimura S. Chin S. Kuang S. Scimè A. Devarakonda S. Conroe H. M. Erdjument-Bromage H. Tempst P. Rudnicki M. A. Beier D. R. Spiegelman B. M. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008 454 7207 961 967 2-s2.0-50049122271 10.1038/nature07182
47. Bamshad M. Song C. K. Bartness T. J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. American Journal of Physiology 1999 276 6 R1569 R1578 2-s2.0-0033036199 (Pubitemid 29323518)
48. Mattson M. P. Perspective: does brown fat protect against diseases of aging? Ageing Research Reviews 2010 9 1 69 76 2-s2.0-72149118710 10.1016/j.arr.2009.11.004
49. Hansen J. B. Kristiansen K. Regulatory circuits controlling white versus brown adipocyte differentiation. Biochemical Journal 2006 398 2 153 168 2-s2.0-33748366392 10.1042/BJ20060402 (Pubitemid 44338472)
50. Kopecky J. Clarke G. Enerbäck S. Spiegelman B. Kozak L. P. Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. The Journal of Clinical Investigation 1995 96 6 2914 2923 2-s2.0-0028865142
51. Kopecky J. Hodny Z. Rossmeisl M. Syrovy I. Kozak L. P. Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. American Journal of Physiology 1996 270 5, part 1 E768 E775 2-s2.0-0030013375 (Pubitemid 26181960)
52. Guri A. J. Hontecillas R. Bassaganya-Riera J. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition. Clinical Nutrition 2006 25 6 871 885 2-s2.0-33751006412 10.1016/j.clnu.2006.08.006 (Pubitemid 44743162)
53. Finn P. F. Dice J. F. Proteolytic and lipolytic responses to starvation. Nutrition 2006 22 7-8 830 844 2-s2.0-33745365931 10.1016/j.nut.2006.04.008 (Pubitemid 43947502)
54. Rosen E. D. Spiegelman B. M. PPAR γ: a nuclear regulator of metabolism, differentiation, and cell growth. The Journal of Biological Chemistry 2001 276 41 37731 37734 2-s2.0-0035851187
55. Gosmain Y. Dif N. Berbe V. Loizon E. Rieusset J. Vidal H. Lefai E. Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues. Journal of Lipid Research 2005 46 4 697 705 2-s2.0-19344361859 10.1194/jlr.M400261-JLR200 (Pubitemid 43073279)
56. Boon Yin K. Najimudin N. Muhammad T. S. T. The PPAR γ coding region and its role in visceral obesity. Biochemical and Biophysical Research Communications 2008 371 2 177 179 2-s2.0-43049168651 10.1016/j.bbrc.2008.04.013
57. Wu Z. Xie Y. Morrison R. F. Bucher N. L. R. Farmer S. R. PPAR γ induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBP α during the conversion of 3T3 fibroblasts into adipocytes. The Journal of Clinical Investigation 1998 101 1 22 32 2-s2.0-0031595111 (Pubitemid 28058899)
58. Cagen L. M. Deng X. Wilcox H. G. Park E. A. Raghow R. Elam M. B. Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochemical Journal 2005 385 1 207 216 2-s2.0-12744271884 10.1042/BJ20040162
59. Kim J. B. Wright H. M. Wright M. Spiegelman B. M. ADD1/SREBP1 activates PPAR γ through the production of endogenous ligand. Proceedings of the National Academy of Sciences of the United States of America 1998 95 8 4333 4337 2-s2.0-0032516081 10.1073/pnas.95.8.4333 (Pubitemid 28207912)
60. Fajas L. Schoonjans K. Gelman L. Kim J. B. Najib J. Martin G. Fruchart J. C. Briggs M. Spiegelman B. M. Auwerx J. Regulation of peroxisome proliferator-activated receptor γ expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Molecular and Cellular Biology 1999 19 8 5495 5503 2-s2.0-0032793068 (Pubitemid 29339907)
61. Koh E. H. Park J. Y. Park H. S. Min J. J. Je W. R. Kim M. Sun Y. K. Kim M. S. Kim S. W. In S. P. Jang H. Y. Lee KI. U. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007 56 12 2973 2981 2-s2.0-36849085935 10.2337/db07-0510 (Pubitemid 350223632)
62. Wajchenberg B. L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrine Reviews 2000 21 6 697 738 2-s2.0-0034504237 10.1210/er.21.6.697 (Pubitemid 32113289)
63. Casteilla L. Pénicaud L. Cousin B. Calise D. Choosing an adipose tissue depot for sampling. Factors in selection and depot specificity. Methods in Molecular Biology 2008 456 23 38 2-s2.0-0035228962
64. Chowdhury B. Sjostrom L. Alpsten M. Kostanty J. Kvist H. Lofgren R. A multicompartment body composition technique based on computerized tomography. International Journal of Obesity 1994 18 4 219 234 (Pubitemid 24123457)
65. Hoffstedt J. Arner P. Hellers G. Lönnqvist F. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. Journal of Lipid Research 1997 38 4 795 804 2-s2.0-0030896519 (Pubitemid 27194930)
66. Hajer G. R. van Haeften T. W. Visseren F. L. J. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387
67. Yang Y. K. Chen M. Clements R. H. Abrams G. A. Aprahamian C. J. Harmon C. M. Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes. Cellular Physiology and Biochemistry 2008 22 5-6 531 538 2-s2.0-57649245213 10.1159/000185527
68. Sramkova D. Krejbichova S. Vcelak J. Vankova M. Samalikova P. Hill M. Kvasnickova H. Dvorakova K. Vondra K. Hainer V. Bendlova B. The UCP1 gene polymorphism A-3826G in relation to DM2 and body composition in Czech population. Experimental and Clinical Endocrinology and Diabetes 2007 115 5 303 307 2-s2.0-34249929898 10.1055/s-2007-977732 (Pubitemid 46877863)
69. Arner P. Hellstrom L. Wahrenberg H. Bronnegard M. Beta-adrenoceptor expression in human fat cells from different regions. The Journal of Clinical Investigation 1990 86 5 1595 1600 2-s2.0-0025119716 (Pubitemid 20372609)
70. Virtanen K. A. Lönnroth P. Parkkola R. Peltoniemi P. Asola M. Viljanen T. Tolvanen T. Knuuti J. Rönnemaa T. Huupponen R. Nuutila P. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. Journal of Clinical Endocrinology and Metabolism 2002 87 8 3902 3910 2-s2.0-18544368076 10.1210/jc.87.8.3902 (Pubitemid 34879546)
71. Vidal-Puig A. J. Considine R. V. Jimenez-Liñan M. Werman A. Pories W. J. Caro J. F. Flier J. S. Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. The Journal of Clinical Investigation 1997 99 10 2416 2422 2-s2.0-0030977450 (Pubitemid 27227719)
72. Jamdar S. C. Glycerolipid biosynthesis in rat adipose tissue. Influence of adipose-cell size and site of adipose tissue on triacylglycerol formation in lean and obese rats. Biochemical Journal 1978 170 1 153 160 2-s2.0-0018147323 (Pubitemid 8266367)
73. Palou M. Priego T. Sánchez J. Rodríguez A. M. Palou A. Picó C. Gene expression patterns in visceral and subcutaneous adipose depots in rats are linked to their morphologic features. Cellular Physiology and Biochemistry 2009 24 5-6 547 556 2-s2.0-70450250235 10.1159/000257511
74. Palou M. Sánchez J. Priego T. Rodríguez A. M. Picó C. Palou A. Regional differences in the expression of genes involved in lipid metabolism in adipose tissue in response to short- and medium-term fasting and refeeding. Journal of Nutritional Biochemistry 2010 21 1 23 33 2-s2.0-71749084311 10.1016/j.jnutbio.2008.10.001
75. Frayn K. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002 45 9 1201 1210 2-s2.0-0036381998 10.1007/s00125-002-0873-y
76. Kelley D. E. Thaete F. L. Troost F. Huwe T. Goodpaster B. H. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. American Journal of Physiology 2000 278 5 E941 E948 2-s2.0-0034129495 (Pubitemid 30366413)
77. Smith S. R. Lovejoy J. C. Greenway F. Ryan D. de Jonge L. de la Bretonne J. Volafova J. Bray G. A. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001 50 4 425 435 2-s2.0-0035048503 10.1053/meta.2001.21693 (Pubitemid 32321951)
78. Miyazaki Y. Glass L. Triplitt C. Wajcberg E. Mandarino L. J. DeFronzo R. A. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. American Journal of Physiology 2002 283 6 E1135 E1143 2-s2.0-0036889453 (Pubitemid 35340618)
79. Walker G. E. Verti B. Marzullo P. Savia G. Mencarelli M. Zurleni F. Liuzzi A. Di Blasio A. M. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot. Obesity 2007 15 8 1933 1943 2-s2.0-34548645016 10.1038/oby.2007.231 (Pubitemid 47402225)
80. Cnop M. Landchild M. J. Vidal J. Havel P. J. Knowles N. G. Carr D. R. Wang F. Hull R. L. Boyko E. J. Retzlaff B. M. Walden C. E. Knopp R. H. Kahn S. E. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 2002 51 4 1005 1015 2-s2.0-0036228581 (Pubitemid 34438343)
81. Kadowaki K. Fukino K. Negishi E. Ueno K. Sex differences in PPAR γ expressions in rat adipose tissues. Biological and Pharmaceutical Bulletin 2007 30 4 818 820 2-s2.0-34147180133 10.1248/bpb.30.818 (Pubitemid 46571008)
82. Manolopoulos K. N. Karpe F. Frayn K. N. Gluteofemoral body fat as a determinant of metabolic health. International Journal of Obesity 2010 34 6 949 959 2-s2.0-77953612080 10.1038/ijo.2009.286
83. Snijder M. B. Visser M. Dekker J. M. Goodpaster B. H. Harris T. B. Kritchevsky S. B. de Rekeneire N. Kanaya A. M. Newman A. B. Tylavsky F. A. Seidell J. C. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005 48 2 301 308 2-s2.0-20244380781 10.1007/s00125-004- 1637-7 (Pubitemid 40543303)
84. Seidell J. C. Pérusse L. Després J. P. Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. American Journal of Clinical Nutrition 2001 74 3 315 321 2-s2.0-0034878336 (Pubitemid 32802016)
85. Terry R. B. Stefanick M. L. Haskell W. L. Wood P. D. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: possible protective effects of thigh fat. Metabolism 1991 40 7 733 740 2-s2.0-0025778917 10.1016/0026-0495(91)90093-C
86. Buemann B. Astrup A. Pedersen O. Black E. Holst C. Toubro S. Echwald S. Holst J. J. Rasmussen C. Sørensen T. I. A. Possible role of adiponectin and insulin sensitivity in mediating the favorable effects of lower body fat mass on blood lipids. Journal of Clinical Endocrinology and Metabolism 2006 91 5 1698 1704 2-s2.0-33646413654 10.1210/jc.2005-1062
87. McQuaid S. E. Humphreys S. M. Hodson L. Fielding B. A. Karpe F. Frayn K. N. keith.frayn@oxlip.ox.ac.uk Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids. Diabetes 2010 59 10 2465 2473 10.2337/db10-0678
88. Gallagher D. Kelley D. E. Yim J. E. Spence N. Albu J. Boxt L. Xavier Pi-Sunyer F. Heshka S. Adipose tissue distribution is different in type 2 diabetes. American Journal of Clinical Nutrition 2009 89 3 807 814 2-s2.0-61449209861 10.3945/ajcn.2008.26955
89. Marcus R. L. Addison O. Kidde J. P. Dibble L. E. Lastayo P. C. Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. Journal of Nutrition, Health and Aging 2010 14 5 362 366 2-s2.0-77952700993 10.1007/s12603-010-0081-2
90. Goodpaster B. H. Krishnaswami S. Resnick H. Kelley D. E. Haggerty C. Harris T. B. Schwartz A. V. Kritchevsky S. Newman A. B. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003 26 2 372 379 2-s2.0-0042810882 10.2337/diacare.26.2.372 (Pubitemid 36929058)
91. Boettcher M. Machann J. Stefan N. Thamer C. Häring H. U. Claussen C. D. Fritsche A. Schick F. Intermuscular adipose tissue (IMAT): association with other adipose tissue compartments and insulin sensitivity. Journal of Magnetic Resonance Imaging 2009 29 6 1340 1345 2-s2.0-66749103201 10.1002/jmri.21754
92. Yim J. E. Heshka S. Albu J. Heymsfield S. Kuznia P. Harris T. Gallagher D. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. International Journal of Obesity 2007 31 9 1400 1405 2-s2.0-34548321236 10.1038/sj.ijo.0803621 (Pubitemid 47339927)
93. Albu J. B. Kovera A. J. Allen L. Wainwright M. Berk E. Raja-Khan N. Janumala I. Burkey B. Heshka S. Gallagher D. Independent association of insulin resistance with larger amounts of intermuscular adipose tissue and a greater acute insulin response to glucose in African American than in white nondiabetic women. American Journal of Clinical Nutrition 2005 82 6 1210 1217 2-s2.0-33644697339 (Pubitemid 43779719)
94. Iacobellis G. Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Hormone and Metabolic Research 2008 40 7 442 445 2-s2.0-48349146146 10.1055/s-2008-1062724
95. Rabkin S. W. Epicardial fat: properties, function and relationship to obesity. Obesity Reviews 2007 8 3 253 261 2-s2.0-34247397526 10.1111/j.1467-789X.2006.00293.x (Pubitemid 46632691)
96. Iacobellis G. Sharma A. M. Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Current Pharmaceutical Design 2007 13 21 2180 2184 2-s2.0-34447515817 10.2174/138161207781039670 (Pubitemid 47074050)
97. Sacks H. S. Fain J. N. Human epicardial adipose tissue: a review. American Heart Journal 2007 153 6 907 917 2-s2.0-34249299722 10.1016/j.ahj.2007.03.019 (Pubitemid 46809849)
98. Natale F. Tedesco M. A. Mocerino R. de Simone V. Di Marco G. M. Aronne L. Credendino M. Siniscalchi C. Calabró P. Cotrufo M. Calabró R. Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. European Journal of Echocardiography 2009 10 4 549 555 2-s2.0-67650403810 10.1093/ejechocard/jep002
99. Mazur A. Ostański M. Telega G. Malecka-Tendera E. Is epicardial fat tissue a marker of metabolic syndrome in obese children? Atherosclerosis 2010 211 2 596 600 2-s2.0-77949456902 10.1016/j.atherosclerosis.2010.02.036
100. Sacks H. S. hsacks@hotmail.com Fain J. N. Holman B. Cheema P. Chary A. Parks F. Karas J. Optican R. Bahouth S. W. Garrett E. Wolf R. Y. Carter R. A. Robbins T. Wolford D. Samaha J. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. Journal of Clinical Endocrinology and Metabolism 2009 94 9 3611 3615 10.1210/jc.2009-0571
101. Rodríguez E. Ribot J. Rodríguez A. M. Palou A. PPAR- γ 2 expression in response to cafeteria diet: gender- and depot-specific effects. Obesity Research 2004 12 9 1455 1463 2-s2.0-16544362863 (Pubitemid 41137452)
102. Kontani Y. Wang Y. Kimura K. Inokuma K. I. Saito M. Suzuki-Miura T. Wang Z. Sato Y. Mori N. Yamashita H. UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 2005 4 3 147 155 2-s2.0-23844474515 10.1111/j.1474-9726.2005.00157.x (Pubitemid 41602748)
103. Hamann A. Flier J. S. Lowell B. B. Obesity after genetic ablation of brown adipose tissue. Zeitschrift für Ernahrungswissenschaft 1998 37 supplement 1 1 7 (Pubitemid 28161253)
104. Xiao Q. X. Williams S. M. Grayson B. E. Glavas M. M. Cowley M. A. Smith M. S. Grove K. L. Excess weight gain during the early postnatal period is associated with permanent reprogramming of brown adipose tissue adaptive thermogenesis. Endocrinology 2007 148 9 4150 4159 2-s2.0-34548104365 10.1210/en.2007-0373 (Pubitemid 47295677)
105. Kajimura S. Seale P. Kubota K. Lunsford E. Frangioni J. V. Gygi S. P. Spiegelman B. M. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP- β transcriptional complex. Nature 2009 460 7259 1154 1158 2-s2.0-69349088117 10.1038/nature08262
106. 3agonists. Molecular and Cellular Biology 2009 29 17 4714 4728 10.1128/MCB.01899-08
107. Petrovic N. Shabalina I. G. Timmons J. A. Cannon B. Nedergaard J. Thermogenically competent nonadrenergic recruitment in brown preadipocytes by a PPAR γ agonist. American Journal of Physiology 2008 295 2 E287 E296 2-s2.0-52649150323 10.1152/ajpendo.00035.2008
108. Aleo M. D. Lundeen G. R. Blackwell D. K. Smith W. M. Coleman G. L. Stadnicki S. W. Kluwe W. M. Mechanism and implications of brown adipose tissue proliferation in rats and monkeys treated with the thiazolidinedione darglitazone, a potent peroxisome proliferator-activated receptor- γ agonist. Journal of Pharmacology and Experimental Therapeutics 2003 305 3 1173 1182 2-s2.0-0037799779 10.1124/jpet.102.042648 (Pubitemid 36617996)
109. Haller C. A. Benowitz N. L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. The New England Journal of Medicine 2000 343 25 1833 1838 2-s2.0-0034700454 10.1056/NEJM200012213432502 (Pubitemid 32104128)
110. Belzung F. Raclot T. Groscolas R. Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. American Journal of Physiology 1993 264 6 R1111 R1118 2-s2.0-0027215407 (Pubitemid 23198591)
111. Rustan A. C. Hustvedt B. E. Drevon C. A. Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat. Journal of Lipid Research 1993 34 8 1299 1309 2-s2.0-0027240172 (Pubitemid 23230308)
112. Singer P. Shapiro H. Theilla M. Anbar R. Singer J. Cohen J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Medicine 2008 34 9 1580 1592 2-s2.0-49749141035 10.1007/s00134-008-1142-4
113. Ruzickova J. Rossmeisl M. Prazak T. Flachs P. Sponarova J. Vecka M. Tvrzicka E. Bryhn M. Kopecky J. Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 2004 39 12 1177 1185 2-s2.0-12544260664 10.1007/s11745-004-1345-9
114. Flachs P. Horakova O. Brauner P. Rossmeisl M. Pecina P. Franssen-van Hal N. Ruzickova J. Sponarova J. Drahota Z. Vlcek C. Keijer J. Houstek J. Kopecky J. kopecky@biomed.cas.cz Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce β -oxidation in white fat. Diabetologia 2005 48 11 2365 2375 10.1007/s00125-005-1944-7 (Pubitemid 41618929)
115. Kuda O. Jelenik T. Jilkova Z. Flachs P. Rossmeisl M. Hensler M. Kazdova L. Ogston N. Baranowski M. Gorski J. Janovska P. Kus V. Polak J. Mohamed-Ali V. Burcelin R. Cinti S. Bryhn M. Kopecky J. kopecky@biomed.cas.cz N-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 2009 52 5 941 951 10.1007/s00125-009-1305-z
116. Flachs P. Rossmeisl M. Bryhn M. Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical Science 2009 116 1 1 16 2-s2.0-60549108418 10.1042/CS20070456
117. Rossi A. S. Lombardo Y. B. Lacorte J. M. Chicco A. G. Rouault C. Slama G. Rizkalla S. W. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. American Journal of Physiology 2005 289 2 R486 R494 2-s2.0-23044445184 10.1152/ajpregu.00846.2004 (Pubitemid 41060504)
118. Neschen S. Morino K. Rossbacher J. C. Pongratz R. L. Cline G. W. Sono S. Gillum M. Shulman G. I. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor- γ -dependent mechanism in mice. Diabetes 2006 55 4 924 928 2-s2.0-33745305434 10.2337/diabetes.55.04.06.db05-0985 (Pubitemid 44100165)
119. Berge R. K. Tronstad K. J. Berge K. Rost T. H. Wergedahl H. Gudbrandsen O. A. Skorve J. The metabolic syndrome and the hepatic fatty acid drainage
120. Dyroy E. endre.dyroy@med.uib.no Yndestad A. Ueland T. Antiinflammatory effects of tetradecylthioacetic acid involve both peroxisome proliferator-activated receptor α -dependent and -independent pathways. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 7 1364 1369 10.1161/01.ATV.0000171982.57713.96 (Pubitemid 40923353)
121. Løvås K. Røst T. H. Skorve J. Ulvik R. J. Gudbrandsen O. A. Bohov P. Wensaas A. J. Rustan A. C. Berge R. K. Husebye E. S. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR- α / δ activation and increased mitochondrial fatty acid oxidation. Diabetes, Obesity and Metabolism 2009 11 4 304 314 2-s2.0-61549119476 10.1111/j.1463-1326.2008.00958.x
122. Madsen L. Guerre-Millo M. Flindt E. N. Berge K. Tronstad K. J. Bergene E. Sebokova E. Rustan A. C. Jensen J. Mandrup S. Kristiansen K. Klimes I. Staels B. Berge R. K. Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance. Journal of Lipid Research 2002 43 5 742 750 2-s2.0-0036255454 (Pubitemid 34477901)
123. Wensaas A. J. Rustan A. C. Rokling-Andersen M. H. Caesar R. Jensen J. Kaalhus O. Graff B. A. Gudbrandsen O. A. Berge R. K. Drevon C. A. Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. Diabetes, Obesity and Metabolism 2009 11 11 1034 1049 2-s2.0-70350150664 10.1111/j.1463-1326.2009.01092.x
124. Rokling-Andersen M. H. Rustan A. C. Wensaas A. J. Kaalhus O. Wergedahl H. Røst T. H. Jensen J. Graff B. A. Caesar R. Drevon C. A. Marine n-3 fatty acids promote size reduction of visceral adipose depots, without altering body weight and composition, in male Wistar rats fed a high-fat diet. British Journal of Nutrition 2009 102 7 995 1006 2-s2.0-73749088581 10.1017/S0007114509353210
125. Spiegelman B. M. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Foundation Symposium 2007 287 60 63
126. Semple R. K. Crowley V. C. Sewter C. P. Laudes M. Christodoulides C. Considine R. V. Vidal-Puig A. O'Rahilly S. sorahill@hgmp.mrc.ac.uk Expression of the thermogenic nuclear hormone receptor coactivator PGC-1 α is reduced in the adipose tissue of morbidly obese subjects. International Journal of Obesity 2004 28 1 176 179 10.1038/sj.ijo.0802482 (Pubitemid 38142007)
127. Madsen L. Frøyland L. Grav H. J. Berge R. K. Up-regulated Δ 9 -desaturase gene expression by hypolipidemic peroxisome-proliferating fatty acids results in increased oleic acid content in liver and VLDL: accumulation of a Δ 9 -desaturated metabolite of tetradecylthioacetic acid. Journal of Lipid Research 1997 38 3 554 563 2-s2.0-0030904957
128. Fredriksen J. Ueland T. Dyrøy E. Halvorsen B. Melby K. Melbye L. Skalhegg B. S. Bohov P. Skorve J. Berge R. K. Aukrust P. Frøland S. S. Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy. European Journal of Clinical Investigation 2004 34 10 709 715 2-s2.0-7044284924 10.1111/j.1365-2362.2004.01410.x (Pubitemid 39423029)
129. Hallgren P. Korsback S. Sjostrom L. Measurements of adipose tissue respiration in a closed chamber using an oxygen sensor: methodological considerations. Journal of Lipid Research 1986 27 9 996 1005 2-s2.0-0022982350 (Pubitemid 17179142)
130. Cannon B. Nedergaard J. Studies of thermogenesis and mitochondrial function in adipose tissues. Methods in Molecular Biology 2008 456 109 121 2-s2.0-48049121102 10.1007/978-1-59745-245-8-8
131. Mori Y. Murakawa Y. Okada K. Horikoshi H. Yokoyama J. Tajima N. Ikeda Y. Effect of troglitazone on body fat distribution in type 2 diabetic patients. Diabetes Care 1999 22 6 908 912 2-s2.0-0032969421 10.2337/diacare.22.6.908 (Pubitemid 29241043)
132. Chaput E. Saladin R. Silvestre M. Edgar A. D. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochemical and Biophysical Research Communications 2000 271 2 445 450 2-s2.0-0034630720 10.1006/bbrc.2000.2647 (Pubitemid 30444746)
133. de Souza C. J. Eckhardt M. Gagen K. Dong M. Chen W. Laurent D. Burkey B. F. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. Diabetes 2001 50 8 1863 1871 2-s2.0-0035430576 (Pubitemid 33641608)
134. Fissoune R. rachida.fissoune@univ-lyon1.fr Pellet N. Chaabane L. Contard F. Guerrier D. Briguet A. Evaluation of adipose tissue distribution in obese fa/fa Zucker rats by in vivo MR imaging: effects of peroxisome proliferator-activated receptor agonists. MAGMA 2004 17 3-6 229 235 10.1007/s10334-004-0088-y (Pubitemid 40362306)
135. Fernandes-Santos C. Carneiro R. E. de Souza Mendonca L. Aguila M. B. Mandarim-de-Lacerda C. A. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Nutrition 2009 25 7-8 818 827 2-s2.0-67349156361 10.1016/j.nut.2008.12.010
136. Forman B. M. Chen J. Evans R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proceedings of the National Academy of Sciences of the United States of America 1997 94 9 4312 4317 10.1073/pnas.94.9.4312 (Pubitemid 27194238)
137. Raspé E. Madsen L. Lefebvre A. M. Leitersdorf I. Gelman L. Peinado-Onsurbe J. Dallongeville J. Fruchart J. C. Berge R. Staels B. Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPAR α activation. Journal of Lipid Research 1999 40 11 2099 2110 2-s2.0-0032740190 (Pubitemid 29523436)
138. Westergaard M. Henningsen J. Svendsen M. L. Johansen C. Jensen U. B. Schrøder H. D. Kratchmarova I. Berge R. K. Iversen L. Bolund L. Kragballe K. Kristiansen K. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. Journal of Investigative Dermatology 2001 116 5 702 712 2-s2.0-17744392617 10.1046/j.1523-1747.2001.01329.x (Pubitemid 32467648)
139. Lanni A. Mancini F. P. Sabatino L. Silvestri E. Franco R. de Rosa G. Goglia F. Colantuoni V. De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats. FEBS Letters 2002 525 1-3 7 12 2-s2.0-0037077726 10.1016/S0014-5793(02)02828-4
140. Grav H. J. Tronstad K. J. Gudbrandsen O. A. Berge K. Fladmark K. E. Martinsen T. C. Waldum H. Wergedahl H. Berge R. K. rolf.berge@med.uib.no Changed energy state and increased mitochondrial β -oxidation rate in liver of rats associated with lowered proton electrochemical potential and stimulated uncoupling protein 2 (UCP-2) expression. Evidence for peroxisome proliferator-activated receptor- α independent induction of UCP-2 expression. The Journal of Biological Chemistry 2003 278 33 30525 30533 10.1074/jbc.M303382200 (Pubitemid 36994556)
141. Bonnard C. Durand A. Peyrol S. Chanseaume E. Chauvin M. A. Morio B. Vidal H. Rieusset J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. The Journal of Clinical Investigation 2008 118 2 789 800 2-s2.0-38849199866 10.1172/JCI32601 (Pubitemid 351206566)
142. Maddux B. A. bmaddux@itsa.ucsf.edu See W. Lawrence Jr. J. C. Goldfine A. L. Goldfine I. D. Evans J. L. Protection against oxidative stress-induced insulin resistance in rat l6 muscle cells by micromolar concentrations of α -lipoic acid. Diabetes 2001 50 2 404 410 (Pubitemid 32127299)
143. Evans J. L. Maddux B. A. Goldfine I. D. The molecular basis for oxidative stress-induced insulin resistance. Antioxidants and Redox Signaling 2005 7 7-8 1040 1052 2-s2.0-22044443268 10.1089/ars.2005.7.1040 (Pubitemid 40967154)
144. Muna Z. A. Bolann B. J. Chen X. Songstad J. Berge R. K. Tetradecylthioacetic acid and tetradecylselenoacetic acid inhibit lipid peroxidation and interact with superoxide radical. Free Radical Biology and Medicine 2000 28 7 1068 1078 2-s2.0-0034106606 10.1016/S0891-5849(00)00196-9 (Pubitemid 30314705)
145. Muna Z. A. Gudbrandsen O. A. Wergedahl H. Bohov P. Skorve J. Berge R. K. Inhibition of rat lipoprotein oxidation after tetradecylthioacetic acid feeding. Biochemical Pharmacology 2002 63 6 1127 1135 2-s2.0-0037087502 10.1016/S0006-2952(01)00934-0 (Pubitemid 34267028)
146. Berge R. K. Skorve J. Tronstad K. J. Berge K. Gudbrandsen O. A. Grav H. Metabolic effects of thia fatty acids. Current Opinion in Lipidology 2002 13 3 295 304 2-s2.0-0035985746 10.1097/00041433-200206000-00010 (Pubitemid 34592287)
147. Kuiper K. K. J. Muna Z. A. Erga K. S. Dyroy E. Svendsen E. Berge R. K. Nordrehaug J. E. Tetradecylthioacetic acid reduces stenosis development after balloon angioplasty injury of rabbit iliac arteries. Atherosclerosis 2001 158 2 269 275 2-s2.0-0034813675 10.1016/S0021-9150(01)00417-8 (Pubitemid 32913635)
148. Glosli H. Gudbrandsen O. A. Mullen A. J. Down-regulated expression of PPAR α target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNF α Biochimica et Biophysica Acta 2005 1734 3 235 246 10.1016/j.bbalip.2005.02.011 (Pubitemid 40805080)